Lipids and Lipoproteins in Risk Prediction

Area of Science:

• Cardiology
• Lipidology
• Preventive Medicine

Background:

• Ischemic heart disease (IHD) is the primary global cause of mortality.
• Low-density lipoprotein cholesterol (LDL-C) is causally linked to atherosclerotic cardiovascular disease (ASCVD).
• Despite LDL-C lowering, residual cardiovascular risk persists in many patients.

Purpose of the Study:

• To evaluate the role of alternative lipoprotein factors beyond LDL-C in cardiovascular risk prediction.
• To explore potential improvements in identifying high-risk individuals using novel lipid markers.
• To assess the clinical utility of advanced lipoprotein analysis in managing residual risk.

Main Methods:

• Review of current literature on lipid biomarkers and cardiovascular risk.
• Analysis of studies comparing LDL-C with other lipoprotein metrics.
• Examination of emerging technologies for lipoprotein profiling.

Main Results:

• Evidence suggests certain lipoprotein factors may offer superior risk stratification compared to LDL-C alone.
• These alternative markers show promise in identifying patients with persistent residual risk.
• Advanced lipoprotein analysis, though not universally available, demonstrates potential for enhanced prediction in specific populations.

Conclusions:

• Optimizing cardiovascular risk assessment may require considering factors beyond LDL-C.
• Further research and technological integration are needed to leverage novel lipoprotein insights for improved patient outcomes.
• Personalized risk prediction models incorporating advanced lipid profiles could refine preventive strategies for IHD.